Sanofi India share price

Moderate risk
  • 24%Low risk
  • 24%Moderate risk
  • 24%Balanced risk
  • 24%High risk
  • 24%Extreme risk
  • 6,035.00(0.50%)
    June 23, 2025 15:25:01 PM IST
    • NSE
    • BSE
  • Vol : 6.57K (NSE + BSE)
    Last 20 day avg : 6.79 K

Sanofi India is trading 0.50% upper at Rs 6,035.00 as compared to its last closing price. Sanofi India has been trading in the price range of 6,035.00 & 5,952.95. Sanofi India has given -1.56% in this year & -1.62% in the last 5 days. Sanofi India has TTM P/E ratio 36.50 as compared to the sector P/E of 22.54.There are 2 analysts who have initiated coverage on Sanofi India. There are 1 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 119.50 Crores in its last quarter.Listed peers of Sanofi India include Natco Pharma (-0.84%), Caplin Point Laboratories (-1.28%), Sanofi India (0.50%).The Mutual Fund holding in Sanofi India was at 11.26% in 31 Mar 2025. The MF holding has increased from the last quarter. The FII holding in Sanofi India was at 5.58% in 31 Mar 2025. The FII holding has decreased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Key Metrics

Updated on Jun 24, 2025, 01:08 AM UTC

  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    1.94
    Higher than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    16.13
    Higher than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    35.03
    Higher than historical values
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    0.60
    Low volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.02
    Higher than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
5,952.95
Highest
6,035.00
52 week range
Lowest
4,145.90
Highest
7,593.60
Sanofi India Financials
Financials
Financials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
View all
  • Income
  • Balance Sheet
  • Cash Flow
Loading...
Units in the chart are in crores
Insights
  • Financial
  • Valuation
    • financial-insightsCompany is profitable
    • financial-insightsThe company's revenue grew in June quarter by 4.91% from Rs 535.90 crore to Rs 510.80 crore, year-on-year
    • financial-insightsThe company's profit declined by 12.52% year-on-year during the June quarter, dropping from Rs 136.60 crore to Rs 119.50 crore
    • financial-insightsThe debt to equity of the company is higher than the industry median
    • financial-insightsCompany can comfortably pay off its interest obligations with its earnings
Sanofi India Technical Analysis
Pivot Level - classic
Info
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
  • R1
  • 6,380.98
  • R2
  • 6,553.02
  • R3
  • 6,767.03
Pivot6,166.97
  • S1
  • 5,994.93
  • S2
  • 5,780.92
  • S3
  • 5,608.88
Short Term
Info
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Info
Considers price movement over the last 6 months
Not Available
  • Very Bearish
  • Bearish
  • Neutral
  • Very Bullish
  • Bullish
Trends unavailable at the moment.
Sanofi India Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Natco Pharma
Bearish
867.95-0.8415,545.848.312.060.690.06
Caplin Point Laboratories
Neutral
2,022.00-1.2815,468.5029.125.450.270.10
Sanofi India
Moderately Bearish
6,035.000.5013,898.6140.6016.081.951.63
Alivus Life Sciences
Bearish
993.00-0.7112,112.2825.264.342.251.81
Granules India
Bearish
497.452.1812,128.8624.723.180.3112.67
Sanofi India Shareholding
View All
Shareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
    No Data
    Shareholding pattern for Sanofi India is currently unavailable
    Please check back later.
    Shareholding Insights
    • InsightsPromoter(s) holds a high stake in the company at 60.40%
    • InsightsFIIs are invested in this company
    • InsightsFIIs holding has decreased by 0.06 percentage points from previous quarter
    • InsightsMutual Funds holding has increased by 0.21 percentage points from previous quarter
    Mutual Fund Ownership
    View all
    Baroda BNP Paribas Small Cap Fund Regular Growth
    NA
    • Amount Invested (Cr.) 25.41
    • % of AUM 1.97
    Nippon India Pharma Fund - Growth
    NA
    • Amount Invested (Cr.) 142.60
    • % of AUM 1.71
    PGIM India Healthcare Fund Regular Growth
    NA
    • Amount Invested (Cr.) 1.80
    • % of AUM 1.65
    Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth
    NA
    • Amount Invested (Cr.) 11.95
    • % of AUM 1.47
    Baroda BNP Paribas Mid Cap Fund Regular Plan Growth
    3/5
    • Amount Invested (Cr.) 26.05
    • % of AUM 1.22
    Sanofi India Corporate Actions
    View all
    • Board Meetings
    • AGM
    • Dividends
    • Bonus
    • Split
    • Rights
    Meeting DatePurpose
    2025-05-14Quarterly Results
    2025-02-27Audited Results & Final Dividend
    2024-11-07Quarterly Results
    2024-07-26Quarterly Results
    2024-05-13Quarterly Results
    About the company Sanofi India
    • IndustryBiotechnology & Drugs
    • ISININE058A01010
    • BSE Code500674
    • NSE CodeSANOFI
    Sanofi India Limited is an India-based company, which is engaged in the business of manufacturing and trading of drugs and pharmaceuticals. The Company produces pharmaceutical formulations, dosage forms and offer a range of medicines across various therapeutic areas. Its product portfolio is focused on five therapeutic areas: diabetes, epilepsy, cardiology, allergy and pain care. In the diabetes area, the Company has an insulin portfolio under the brand name of Lantus, which helps in controlling high blood sugar in adults and children with diabetes mellitus. It also provides Toustar pen, along with dedicated Toujeo cartridges, addressing the need for a reusable delivery device. Combiflam, its product, helps to reduce pain and inflammation in conditions like headache, muscle and joint pain, and also reduces fever. Its brands also include Cardace, Allegra, Avil and Frisium. The Company has its own manufacturing facility in Goa. It has around 12 contract manufacturing organizations.
    • Management Info
    • Rachid AyariChief Financial Officer, Whole Time Director
    • Arjun ThakkarCompliance Officer, Company Secretary
    • Renee AmonkarWhole Time Director and Site Director, Goa
    • Nitin AroraIndia Partnerships Lead
    • N. Suresh BabuSales & Customer Engagement Head - Diabetes
    • Bratin BagSenior Director - Ethics and Business Integrity, South Asia
    • Sudipta ChakrabortyHead of Legal, India
    • Arvind GadekarMedical Lead - International Pharma SE Asia & India
    • Vinifer GandhiIndia Communications & CSR Lead
    • Surabhi KaulPeople & Culture Director, India
    Sanofi India Share Price FAQs

    Sanofi India is trading at 6035.00 as on Mon Jun 23 2025 09:55:01. This is 0.50% upper as compared to its previous closing price of 6005.10.

    The market capitalization of Sanofi India is 13898.61 Cr as on Mon Jun 23 2025 09:55:01.

    The average broker rating on Sanofi India is Strong Buy. The breakup of analyst rating is given below -

    • 1 analysts have given a strong buy rating
    • 1 analysts have given a buy rating
    • 0.00 analysts have given a hold rating
    • 0.00 analysts have given a sell rating
    • 0.00 analysts have given a strong sell rating

    The 52 wk high for Sanofi India is 7593.60 whereas the 52 wk low is 4145.90

    Sanofi India can be analyzed on the following key metrics -

    • TTM P/E: 36.50
    • Sector P/E: 22.54
    • Dividend Yield: 1.94%
    • D/E ratio: -

    Sanofi India reported a net profit of 413.30 Cr in 2024.

    The Mutual Fund Shareholding was 11.26% at the end of 31 Mar 2025.